$KPEA
Kun Peng International Ltd. Stock $kpea

$kpea Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000149315224002378 Filed on January 16, 2024

Income Statement

Concept	2024 Q1	2023
Revenue	$364.5K	$3.917M
YoY Change	14.28%	552.89%
Cost Of Revenue	$99.46K	$433.2K
YoY Change	38.06%	-63.77%
Gross Profit	$265.1K	$3.484M
YoY Change	7.35%	-44.82%
Gross Profit Margin	72.72%	88.94%
Selling, General & Admin	$848.7K	$5.733M
YoY Change	-10.47%	-31.25%
% of Gross Profit	320.19%	164.55%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$21.22K	$60.17K
YoY Change	37.49%	8.08%
% of Gross Profit	8.01%	1.73%
Operating Expenses	$848.7K	$5.733M
YoY Change	-10.47%	-31.11%
Operating Profit	-$583.6K	-$2.249M
YoY Change	-16.74%	12.02%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$440.00	$99.68K
YoY Change	-100.4%	186.68%
Pretax Income	-$584.1K	-$2.149M
YoY Change	-1.34%	8.94%
Income Tax	$13.36K
% Of Pretax Income
Net Earnings	-$577.0K	-$2.149M
YoY Change	-2.54%	17.26%
Net Earnings / Revenue	-158.3%	-54.86%
Basic Earnings Per Share	$0.00	-$0.01
Diluted Earnings Per Share	$0.00	-$0.01
COMMON SHARES
Basic Shares Outstanding	400.0M shares	400.0M shares
Diluted Shares Outstanding	400.0M shares	400.0M shares

Balance Sheet

Concept	2024 Q1	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$21.54K	$457.6K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$41.38K	$107.3K
Prepaid Expenses	$170.1K	$74.04K
Receivables	$12.49K
Other Receivables	$245.0K	$23.06K
Total Short-Term Assets	$504.4K	$661.9K
YoY Change	-30.54%	-27.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$98.05K	$72.55K
YoY Change	-8.78%	-45.87%
Goodwill
YoY Change
Intangibles	$2.656K	$2.806K
YoY Change	-16.21%	34.77%
Long-Term Investments
YoY Change
Other Assets	$10.63K	$3.245K
YoY Change	76.2%	-60.98%
Total Long-Term Assets	$474.2K	$600.0K
YoY Change	-30.61%	-30.48%
TOTAL ASSETS
Total Short-Term Assets	$504.4K	$661.9K
Total Long-Term Assets	$474.2K	$600.0K
Total Assets	$978.6K	$1.262M
YoY Change	-30.57%	-29.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue	$938.9K	$2.149M
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$7.178M	$6.186M
YoY Change	15.99%	19.6%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$95.91K
YoY Change		-63.69%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.178M	$6.186M
Total Long-Term Liabilities		$95.91K
Total Liabilities	$7.178M	$6.282M
YoY Change	13.66%	15.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$6.901M	-$5.803M
YoY Change	37.84%	58.82%
Common Stock	$40.00K	$40.00K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$5.884M	-$4.739M
YoY Change
Total Liabilities & Shareholders Equity	$978.6K	$1.262M
YoY Change	-30.57%	-29.13%

Cashflow Statement

Concept	2024 Q1	2023
OPERATING ACTIVITIES
Net Income	-$577.0K	-$2.149M
YoY Change	-2.54%	17.26%
Depreciation, Depletion And Amortization	$21.22K	$60.17K
YoY Change	37.49%	8.08%
Cash From Operating Activities		-$427.0K
YoY Change		-73.18%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$606.00
YoY Change		-99.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$644.8K
YoY Change
NET CHANGE
Cash From Operating Activities		-$427.0K
Cash From Investing Activities		-$606.00
Cash From Financing Activities		$644.8K
Net Change In Cash		$190.4K
YoY Change		-110.62%
FREE CASH FLOW
Cash From Operating Activities		-$427.0K
Capital Expenditures
Free Cash Flow		-$427.0K
YoY Change		-75.33%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001502557
CY2022Q3	us-gaap	Inventory Net InventoryNet		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2023	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits		usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2022	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent		usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q3	KPEA	Inter Company Receivables Current InterCompanyReceivablesCurrent		usd
CY2023Q3	KPEA	Inter Company Receivables Non Current InterCompanyReceivablesNonCurrent		usd
CY2023Q3	KPEA	Investment In Subsidiary Current InvestmentInSubsidiaryCurrent		usd
CY2023Q3	KPEA	Inter Company Payables InterCompanyPayables		usd
CY2022Q3	KPEA	Inter Company Receivables Current InterCompanyReceivablesCurrent		usd
CY2022Q3	KPEA	Inter Company Receivables Non Current InterCompanyReceivablesNonCurrent		usd
CY2022Q3	KPEA	Inter Company Payables InterCompanyPayables		usd
CY2023	KPEA	Intercompany Revenue IntercompanyRevenue		usd
CY2023	KPEA	Intercompany Operating Expenses IntercompanyOperatingExpenses		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	KPEA	Intercompany Revenue IntercompanyRevenue		usd
CY2022	KPEA	Intercompany Operating Expenses IntercompanyOperatingExpenses		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	KPEA	Intercompany Receivables IntercompanyReceivables		usd
CY2023	KPEA	Intercompany Payable IntercompanyPayable		usd
CY2022	KPEA	Intercompany Receivables IntercompanyReceivables		usd
CY2022	KPEA	Intercompany Payable IntercompanyPayable		usd
CY2023Q3	KPEA	Shortterm Borrowing To Third Parties ShorttermBorrowingToThirdParties		usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods		usd
CY2022Q3	us-gaap	Inventory Net InventoryNet		usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit		usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit		usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	KPEA	Deferred Tax Assets Staff Education Expense DeferredTaxAssetsStaffEducationExpense		usd
CY2023Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree		usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour		usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive		usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree		usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour		usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive		usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	333-169805
CY2023	dei	Entity Registrant Name EntityRegistrantName	KUN PENG INTERNATIONAL LTD.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	32-0538640
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	1F, Building 3, No 1001 Huihe South Street
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Banbidian Village
CY2023	dei	Entity Address Address Line3 EntityAddressAddressLine3	Gaobeidian Town, Chaoyang District
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Beijing
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	100025
CY2023	dei	City Area Code CityAreaCode	86
CY2023	dei	Local Phone Number LocalPhoneNumber	10-87227012
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	Yes
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Public Float EntityPublicFloat	32127315	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	400000000	shares
CY2023	dei	Auditor Name AuditorName	J&S Associate PLT
CY2023	dei	Auditor Firm AuditorFirmId	6743
CY2023	dei	Auditor Location AuditorLocation	Malaysia
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	457580	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	267131	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	74044	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	268306	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	107263	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	661947	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	917479	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	72552	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	134023	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2806	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2082	usd
CY2023Q3	us-gaap	Security Deposit SecurityDeposit	41999	usd
CY2022Q3	us-gaap	Security Deposit SecurityDeposit	43062	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	479427	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	675655	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3245	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8317	usd
CY2023Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	600029	usd
CY2022Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	863139	usd
CY2023Q3	us-gaap	Assets Assets	1261976	usd
CY2022Q3	us-gaap	Assets Assets	1780618	usd
CY2023Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	2151900	usd
CY2022Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1538741	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2149238	usd
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2960357	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	63653	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	53890	usd
CY2023Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	184357	usd
CY2022Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	47330	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	318422	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	304753	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6185690	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5172077	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	95907	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	264124	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	95907	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	264124	usd
CY2023Q3	us-gaap	Liabilities Liabilities	6281597	usd
CY2022Q3	us-gaap	Liabilities Liabilities	5436201	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	400000000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	400000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	400000000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	400000000	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	40000	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	40000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	597801	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	-40000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5803162	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3653996	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	426741	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	279367	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-4738620	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-3374629	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	-281001	usd
CY2022Q3	us-gaap	Minority Interest MinorityInterest	-280954	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-5019621	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3655583	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1261976	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1780618	usd
CY2022Q4	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	forward stock split 10:1
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3917335	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7510059	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	433221	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	1195624	usd
CY2023	us-gaap	Gross Profit GrossProfit	3484114	usd
CY2022	us-gaap	Gross Profit GrossProfit	6314435	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2416372	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1680560	usd
CY2023	us-gaap	Selling Expense SellingExpense	3316631	usd
CY2022	us-gaap	Selling Expense SellingExpense	6641485	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	5733003	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	8322045	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-2248889	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-2007610	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	1009	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	1836	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	98667	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	32933	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	99676	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	34769	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2149213	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1972841	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-2149213	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-1972841	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-47	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-139950	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2149166	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1832891	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	147374	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	335412	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2001839	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1637429	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-47	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-115921	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2001792	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1521508	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.005
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.005
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.005
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.005
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	400000000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	400000000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	400000000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	400000000	shares
CY2022Q4	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	forward stock split 10:1
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3655583	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	637801	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2149166	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-47	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	147374	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-5019621	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2018154	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1832891	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-139950	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	335412	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3655583	usd
CY2022Q4	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	forward stock split 10:1
CY2023	us-gaap	Profit Loss ProfitLoss	-2149213	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-1972841	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	60528	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	55932	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	326255	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	386152	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	318999	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3752	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-199130	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-32770	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-42582	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-50351	usd
CY2022	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-46802	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	110954	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	671836	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	257078	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-763453	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	142789	usd
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	11474	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-45723	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	1094095	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	251175	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	142950	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-206303	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-271259	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-500460	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-427030	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1592130	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	139155	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	606	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-606	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-139155	usd
CY2023	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	644803	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	644803	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-26718	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-61269	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	190449	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1792554	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	267131	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2059685	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	457580	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	267131	usd
CY2023	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	113012	usd
CY2022	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	750486	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	400000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	400000000	shares
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84E_eus-gaap--UseOfEstimates_zXikbyHlbtbf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_zk3LYBTiWZC3">Use of Estimates and Assumptions</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimate and assumptions that impact the presented amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the presented amounts of revenues and expenses during the period. Actual results may differ from those estimates. Significant estimates during the year ended September 30, 2023 and 2022 include the collectability of receivables, the useful lives of long-lived assets and intangibles, assumptions used in assessing impairment of long-lived assets, valuation of accruals for expenses and tax due.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-427030	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-2149213	usd
CY2023Q3	KPEA	Working Capital Deficit WorkingCapitalDeficit	5523743	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	600000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	426741	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	279367	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	65612	usd
CY2023	us-gaap	Selling Expense SellingExpense	3316631	usd
CY2022	us-gaap	Selling Expense SellingExpense	6641485	usd
CY2023	KPEA	Sales Commissions Expense SalesCommissionsExpense	2362078	usd
CY2022	KPEA	Sales Commissions Expense SalesCommissionsExpense	5844846	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zNGh0hLDGI5c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_zaXBQJ69nXyl">Concentration of Risk</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit risk</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and other receivables. As September 30, 2023 and 2022, $<span id="xdx_906_eus-gaap--Deposits_iI_c20230930_zx243zL96bX4" title="Deposits">428,088</span> (RMB<span id="xdx_906_eus-gaap--Deposits_iI_uRMB_c20230930_znmcuBOcLvG7" title="Deposits">3,123,333</span>) and $<span id="xdx_907_eus-gaap--Deposits_iI_c20220930_zW0IWWc1kLe6" title="Deposits">252,512</span> (RMB<span id="xdx_900_eus-gaap--Deposits_iI_uRMB_c20220930_zL4rGI1y28Q" title="Deposits">1,796,861</span>), respectively, were deposited with various major financial institutions located in the PRC. While management believes that these financial institutions are of high credit quality, it also continually monitors their credit worthiness.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically, deposits in Chinese banks are secure due to state policy to protect depositor interests. However, China promulgated a Bankruptcy Law in August 2006 that came into effect on June 1, 2007, which contains a separate article expressly stating that the State Council may promulgate implementation measures to provide for the bankruptcy of Chinese banks based on the Bankruptcy Law. Under the current Bankruptcy Law, a Chinese bank may file bankruptcy if it deems itself to be insolvent. In addition, since China’s concession to the World Trade Organization, foreign banks have been gradually permitted to operate in China and have intensified competition in many aspects, especially since the opening of the Renminbi business to foreign banks in late 2006. Therefore, the risk of bankruptcy at the institutions that the Company maintains deposits has increased. In the event of bankruptcy, the Company is unlikely to reclaim its deposits in full since it is unlikely to be classified as a secured creditor under PRC laws.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks of variable interest entity structure</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the opinion of management, (i) the corporate structure of the Company is in compliance with existing PRC laws and regulations; (ii) the VIE Arrangements are valid and binding, and do not result in any violation of PRC laws or regulations currently in effect; and (iii) the business operations of the foreign-invested enterprise and the VIE are in compliance with existing PRC laws and regulations in all material respects.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However, there are substantial uncertainties regarding the interpretation and application of current and future PRC laws and regulations. Accordingly, the Company cannot be assured that PRC regulatory authorities will not ultimately take a contrary view to the foregoing opinion of its management. If the current corporate structure of the Company or the VIE Arrangements is found to be in violation of any existing or future PRC laws and regulations, the Company may be required to restructure its corporate structure and operations in the PRC to comply with changing and new PRC laws and regulations. In the opinion of management, the likelihood of loss in respect of the Company’s current corporate structure or the VIE Arrangements is remote based on current facts and circumstances.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>Foreign currency exchange risk</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The value of the RMB against the U.S. dollar and other currencies may fluctuate and is affected by, among other things, changes in political and economic conditions and the foreign exchange policy adopted by the PRC government. It is difficult to predict how market forces or PRC or U.S. government policy may impact the exchange rate between the RMB and the U.S. dollar in the future. There remains significant international pressure on the PRC government to adopt a more flexible currency policy, which could result in greater fluctuation of the RMB against the U.S. dollar. The Company is a holding company and it relies on dividends paid by the Company’s operating subsidiaries in China for its cash needs. Any significant revaluation of the RMB may materially and adversely affect its liquidity and cash flows. To the extent that the Company needs to convert U.S. dollars into RMB for its operations, appreciation of the RMB against the U.S. dollar would have an adverse effect on the RMB amount the Company would receive. Conversely, if the Company decides to convert RMB into U.S. dollars for other business purposes, appreciation of the U.S. dollar against the RMB would have a negative effect on the U.S. dollar amount the Company would receive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>Liquidity risk</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity risk is the risk that the Company will encounter difficulty raising liquid funds to meet commitments as they fall due. See our commitments and contingencies in Note 13 under Item 8, Financial Statements and Supplementary Data. In meeting its liquidity requirements, the Company continues to focus on increasing its revenue through the sale of consumer health care products on its online platform, King Eagle Mall, and promoting its own brand of preventive health care related products on its new online platform to reduce its costs of goods sold, streamlining its overhead costs, or obtaining financing from its stockholders or directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8.1pt; text-align: justify; text-indent: -8.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concentration of customers and vendors</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There was no revenue from customers that individually represent greater than <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20221001__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_z9m9SYw5UU21" title="Concentration risk percentage"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20211001__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zeIks4cfn2m8" title="Concentration risk percentage">10</span></span>% of the total revenues for the years ended September 30, 2023, and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended September 30, 2023, three major vendors accounted for <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20221001__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorOneMember_zc0Df2L0YVq2">35</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20221001__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorTwoMember_zgYe9M0eKrbf">25</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20221001__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorThreeMember_zjFpNT6WJfM">12</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the Company’s total cost of sales.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended September 30, 2022, four major vendors accounted for <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20211001__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorOneMember_zGqVWym6vJTe" title="Concentration risk percentage">18</span>%, <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20211001__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorTwoMember_zjI6fWNPlNIl" title="Concentration risk percentage">16</span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20211001__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorThreeMember_zEsmcXCRUWWh" title="Concentration risk percentage">16</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20211001__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorFourMember_z0gBQweaMXGf" title="Concentration risk percentage">12</span>% of the Company’s total cost of sales.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Deposits Deposits	428088	usd
CY2023Q3	us-gaap	Deposits Deposits	3123333
CY2022Q3	us-gaap	Deposits Deposits	252512	usd
CY2022Q3	us-gaap	Deposits Deposits	1796861
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	457580	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	74044	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	107263	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	661947	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	72552	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2806	usd
CY2023Q3	us-gaap	Security Deposit SecurityDeposit	41999	usd
CY2023Q3	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	3245	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	479427	usd
CY2023Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	600029	usd
CY2023Q3	us-gaap	Assets Assets	1261976	usd
CY2023Q3	KPEA	Trade Payable TradePayable	2067831	usd
CY2023Q3	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	84069	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2149238	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	63653	usd
CY2023Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	184357	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	318422	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6185690	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	95907	usd
CY2023Q3	us-gaap	Liabilities Liabilities	6281597	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-4738620	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	-281001	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-5019621	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1261976	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	267131	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	917479	usd
CY2022Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	863139	usd
CY2022Q3	us-gaap	Assets Assets	1780618	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5172077	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	264124	usd
CY2022Q3	us-gaap	Liabilities Liabilities	5436201	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-3374629	usd
CY2022Q3	us-gaap	Minority Interest MinorityInterest	-280954	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3655583	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1780618	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3917335	usd
CY2023	KPEA	Cost Of Revenue And Related Tax CostOfRevenueAndRelatedTax	433221	usd
CY2023	us-gaap	Gross Profit GrossProfit	3484114	usd
CY2023	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	5733003	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-2248889	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	99676	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2149213	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-2149213	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7510059	usd
CY2022	KPEA	Cost Of Revenue And Related Tax CostOfRevenueAndRelatedTax	1195624	usd
CY2022	us-gaap	Gross Profit GrossProfit	6314435	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	8322045	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-2007610	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-2007610	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	34769	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	34769	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1972841	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1972841	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-1972841	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-1972841	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-2149213	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-427030	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-606	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	644803	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-26718	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-1972841	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-1972841	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1592130	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-139155	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-61269	usd
CY2023Q3	KPEA	Prepaid Rent And Building Management And Utilities PrepaidRentAndBuildingManagementAndUtilities	19211	usd
CY2022Q3	KPEA	Prepaid Rent And Building Management And Utilities PrepaidRentAndBuildingManagementAndUtilities	23324	usd
CY2023Q3	us-gaap	Supplies Supplies	32195	usd
CY2022Q3	us-gaap	Supplies Supplies	202150	usd
CY2023Q3	us-gaap	Prepaid Taxes PrepaidTaxes	5027	usd
CY2022Q3	us-gaap	Prepaid Taxes PrepaidTaxes	5154	usd
CY2023Q3	KPEA	Prepaid Professional Services PrepaidProfessionalServices	9137	usd
CY2022Q3	KPEA	Prepaid Professional Services PrepaidProfessionalServices	25941	usd
CY2023Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	8474	usd
CY2022Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	11737	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	74044	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	268306	usd
CY2023Q3	us-gaap	Supplies Supplies	32195	usd
CY2022Q3	us-gaap	Supplies Supplies	202150	usd
CY2023Q3	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	9137	usd
CY2022Q3	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	9369	usd
CY2022	us-gaap	Marketing Expense MarketingExpense	16572	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	36092	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	72552	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	134023	usd
CY2023	us-gaap	Depreciation Depreciation	60165	usd
CY2022	us-gaap	Depreciation Depreciation	55666	usd
CY2023Q3	us-gaap	Prepaid Rent PrepaidRent	14111	usd
CY2022Q3	us-gaap	Prepaid Rent PrepaidRent	14735	usd
CY2023Q3	KPEA	Advance To Employees AdvanceToEmployees	2604	usd
CY2022Q3	KPEA	Advance To Employees AdvanceToEmployees	45250	usd
CY2022Q3	KPEA	Shortterm Borrowing To Third Parties ShorttermBorrowingToThirdParties	2188	usd
CY2023Q3	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	6345	usd
CY2022Q3	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	3677	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	107263	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	107263	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	165919	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	170115	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	93367	usd
CY2022Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	16184	usd
CY2022Q2	KPEA	Refund Of Cost Of Unused Services Reclassified To Other Receivables RefundOfCostOfUnusedServicesReclassifiedToOtherReceivables	3677	usd
CY2022Q2	us-gaap	Proceeds From Sale Of Furniture And Fixtures ProceedsFromSaleOfFurnitureAndFixtures	281	usd
CY2022Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3752	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3551	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2449	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	745	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	367	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2806	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2082	usd
CY2023Q3	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	363	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	266	usd
CY2023Q3	KPEA	Advance Payments From Customers AdvancePaymentsFromCustomers	2149238	usd
CY2022Q3	KPEA	Advance Payments From Customers AdvancePaymentsFromCustomers	2960357	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2149238	usd
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2960357	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2149238	usd
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2960357	usd
CY2023Q4	us-gaap	Deferred Revenue Refund Payments1 DeferredRevenueRefundPayments1	1233590	usd
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	400000000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	400000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	400000000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	400000000	shares
CY2023	KPEA	Percentage Of After Tax Profits PercentageOfAfterTaxProfits	0.10	pure
CY2023Q3	KPEA	Percentage Of Registered Capital PercentageOfRegisteredCapital	0.50	pure
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2149213	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1972841	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.034	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.035	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.022	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.003	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.222	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.242	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1362897	usd
CY2022Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	922114	usd
CY2023Q3	KPEA	Deferred Tax Assets Staff Education Expense DeferredTaxAssetsStaffEducationExpense	1691	usd
CY2023Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1364588	usd
CY2022Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	922114	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1364588	usd
CY2022Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	922114	usd
CY2023Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	5618681	usd
CY2022Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	3807069	usd
CY2023	KPEA	Tax Cuts And Jobs Act Percentage Of Taxable Income TaxCutsAndJobsActPercentageOfTaxableIncome	0.80	pure
CY2023	KPEA	Income Tax Expiration Term Period IncomeTaxExpirationTermPeriod	P5Y
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	479427	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	675655	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	318422	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	304753	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	95907	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	264124	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	414329	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	568877	usd
CY2023	us-gaap	Lease Cost LeaseCost	330626	usd
CY2022	us-gaap	Lease Cost LeaseCost	398133	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	331190	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	97074	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	428264	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	13935	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	414329	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	328832	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	328832	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	273520	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	602352	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	33475	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	568877	usd
CY2023	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	271259	usd
CY2022	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	500460	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	113012	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	750486	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y5M19D
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M18D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0431	pure
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0472	pure
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	326255	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	386152	usd

Files In Submission

Name	View Source	Status
kpea-20230930_pre.xml	Edgar Link	unprocessable
kpea-20230930_def.xml	Edgar Link	unprocessable
kpea-20230930_cal.xml	Edgar Link	unprocessable
kpea-20230930_lab.xml	Edgar Link	unprocessable
0001493152-24-002378-index-headers.html	Edgar Link	pending
0001493152-24-002378-index.html	Edgar Link	pending
0001493152-24-002378.txt	Edgar Link	pending
0001493152-24-002378-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-k.htm	Edgar Link	pending
form10-k_002.jpg	Edgar Link	pending
form10-k_003.jpg	Edgar Link	pending
form10-k_005.jpg	Edgar Link	pending
form10-k_006.jpg	Edgar Link	pending
form10-k_007.jpg	Edgar Link	pending
form10-k_008.jpg	Edgar Link	pending
form10-k_009.jpg	Edgar Link	pending
form10-k_01.jpg	Edgar Link	pending
form10-k_010.jpg	Edgar Link	pending
form10-k_011.jpg	Edgar Link	pending
form10-k_012.jpg	Edgar Link	pending
form10-k_013.jpg	Edgar Link	pending
form10-k_014.jpg	Edgar Link	pending
form10-k_015.jpg	Edgar Link	pending
form10-k_016.jpg	Edgar Link	pending
form10-k_017.jpg	Edgar Link	pending
form10-k_018.jpg	Edgar Link	pending
form10-k_019.jpg	Edgar Link	pending
form10-k_020.jpg	Edgar Link	pending
form10-k_021.jpg	Edgar Link	pending
form10-k_022.jpg	Edgar Link	pending
form10-k_023.jpg	Edgar Link	pending
form10-k_024.jpg	Edgar Link	pending
form10-k_025.jpg	Edgar Link	pending
form10-k_026.jpg	Edgar Link	pending
kpea-20230930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
form10-k_htm.xml	Edgar Link	completed
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KPEA
Kun Peng International Ltd. Stock $kpea

2024 Q1 Form 10-K Financial Statement

#000149315224002378 Filed on January 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KPEA Kun Peng International Ltd. Stock $kpea

2024 Q1 Form 10-K Financial Statement

#000149315224002378 Filed on January 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KPEA
Kun Peng International Ltd. Stock $kpea